Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia
Great strides have been made in the treatment of acute myeloid leukemia (AML) resulting in increased number of survivors over all age groups, but especially in patients of reproductive age. Given the gonadotoxicity of high-dose induction chemotherapy and subsequent allogeneic stem cell transplant, i...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2018/9807047 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850170815993085952 |
|---|---|
| author | Rebecca Ye Benjamin Tomlinson Marcos de Lima Ehsan Malek |
| author_facet | Rebecca Ye Benjamin Tomlinson Marcos de Lima Ehsan Malek |
| author_sort | Rebecca Ye |
| collection | DOAJ |
| description | Great strides have been made in the treatment of acute myeloid leukemia (AML) resulting in increased number of survivors over all age groups, but especially in patients of reproductive age. Given the gonadotoxicity of high-dose induction chemotherapy and subsequent allogeneic stem cell transplant, it is paramount that fertility preservation options are discussed and explored at the time of diagnosis as fertility preservation has been associated with greater quality of life in survivors. Starting the conversation early is especially important for female patients given the time needed for all currently available fertility preservation techniques. Furthermore, due to a lack of current guidelines for the optimal timing of treatment, patients often encounter difficulties trying to balance life-saving treatment and fertility preservation. We present a case of female patient of reproductive age diagnosed with AML who opted for ovarian stimulation, oocyte retrieval, and subsequent IVF following a cycle of induction chemotherapy with satisfactory results for both embryo generation and disease treatment. |
| format | Article |
| id | doaj-art-98d6d72468fe4b83aebe1cdc6728b06e |
| institution | OA Journals |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-98d6d72468fe4b83aebe1cdc6728b06e2025-08-20T02:20:25ZengWileyCase Reports in Hematology2090-65602090-65792018-01-01201810.1155/2018/98070479807047Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid LeukemiaRebecca Ye0Benjamin Tomlinson1Marcos de Lima2Ehsan Malek3Case Western Reserve University, Cleveland, OH, USAAdult Hematologic Malignancies and Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USAAdult Hematologic Malignancies and Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USAAdult Hematologic Malignancies and Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USAGreat strides have been made in the treatment of acute myeloid leukemia (AML) resulting in increased number of survivors over all age groups, but especially in patients of reproductive age. Given the gonadotoxicity of high-dose induction chemotherapy and subsequent allogeneic stem cell transplant, it is paramount that fertility preservation options are discussed and explored at the time of diagnosis as fertility preservation has been associated with greater quality of life in survivors. Starting the conversation early is especially important for female patients given the time needed for all currently available fertility preservation techniques. Furthermore, due to a lack of current guidelines for the optimal timing of treatment, patients often encounter difficulties trying to balance life-saving treatment and fertility preservation. We present a case of female patient of reproductive age diagnosed with AML who opted for ovarian stimulation, oocyte retrieval, and subsequent IVF following a cycle of induction chemotherapy with satisfactory results for both embryo generation and disease treatment.http://dx.doi.org/10.1155/2018/9807047 |
| spellingShingle | Rebecca Ye Benjamin Tomlinson Marcos de Lima Ehsan Malek Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia Case Reports in Hematology |
| title | Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia |
| title_full | Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia |
| title_fullStr | Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia |
| title_full_unstemmed | Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia |
| title_short | Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia |
| title_sort | timing embryo preservation for a patient with high risk newly diagnosed acute myeloid leukemia |
| url | http://dx.doi.org/10.1155/2018/9807047 |
| work_keys_str_mv | AT rebeccaye timingembryopreservationforapatientwithhighrisknewlydiagnosedacutemyeloidleukemia AT benjamintomlinson timingembryopreservationforapatientwithhighrisknewlydiagnosedacutemyeloidleukemia AT marcosdelima timingembryopreservationforapatientwithhighrisknewlydiagnosedacutemyeloidleukemia AT ehsanmalek timingembryopreservationforapatientwithhighrisknewlydiagnosedacutemyeloidleukemia |